Drug intelligence / Profile preview

olea europaea pollen extract

Development stage
Phase 3
Lead developer
Leti Pharma
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Intradermal, Subcutaneous
01

Overview

Olea europaea pollen extract is a therapeutic allergen extract prepared from olive tree pollen and used in allergen immunotherapy for patients with hypersensitivity to olive pollen. In the cited LETI Pharma clinical study, the product is described as a modified, depigmented and polymerized allergen extract administered by subcutaneous immunotherapy to reduce allergic symptoms and medication use in patients with olive pollen-induced allergic rhinitis or rhinoconjunctivitis, with or without episodic asthma. Its therapeutic effect is based on allergen-specific immune modulation rather than classical receptor pharmacology, aiming to induce tolerance to olive pollen allergens after repeated exposure.

Brand names
Depigoid
Other names
olea europaea pollen extractolea europaea allergen extractolive pollen extractolea europaea allergenic extract
02

Targets

HLA-DR (Human leukocyte antigen DR)

Beyond the preview

Go deeper on olea europaea pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on olea europaea pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call